These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 27976508)

  • 21. Influence of obesity on progression of non-diabetic chronic kidney disease: a retrospective cohort study.
    Othman M; Kawar B; El Nahas AM
    Nephron Clin Pract; 2009; 113(1):c16-23. PubMed ID: 19590231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Body adiposity predictors of vitamin D status in nondialyzed patients with chronic kidney disease: A cross-sectional analysis in a tropical climate city.
    Barreto Silva MI; Cavalieri VV; Lemos CC; Klein MR; Bregman R
    Nutrition; 2017 Jan; 33():240-247. PubMed ID: 27692990
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk for chronic kidney disease increases with obesity: Health Survey for England 2010.
    MacLaughlin HL; Hall WL; Sanders TA; Macdougall IC
    Public Health Nutr; 2015 Dec; 18(18):3349-54. PubMed ID: 25743030
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Body mass index and preclinical kidney disease in Indian adults aged 40 years and above without chronic kidney disease.
    Sabanayagam C; Wong TY; Liao J; Sethi S; Teo BW
    Clin Exp Nephrol; 2014 Dec; 18(6):919-24. PubMed ID: 24526413
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Waist Circumference and Body Mass Index in Children with Chronic Kidney Disease and Metabolic, Cardiovascular, and Renal Outcomes.
    Patel HP; Saland JM; Ng DK; Jiang S; Warady BA; Furth SL; Flynn JT
    J Pediatr; 2017 Dec; 191():133-139. PubMed ID: 29173296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High muscle-to-fat ratio is associated with lower risk of chronic kidney disease development.
    Jhee JH; Joo YS; Han SH; Yoo TH; Kang SW; Park JT
    J Cachexia Sarcopenia Muscle; 2020 Jun; 11(3):726-734. PubMed ID: 32020762
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of anthropometric obesity measures with chronic kidney disease risk in a non-diabetic patient population.
    Burton JO; Gray LJ; Webb DR; Davies MJ; Khunti K; Crasto W; Carr SJ; Brunskill NJ
    Nephrol Dial Transplant; 2012 May; 27(5):1860-6. PubMed ID: 21965589
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Obesity indices for prediction of chronic kidney disease: 
a cross-sectional study in 26 655 Chinese adults.
    Liu J; Chen Z; Li W; Xu G; Liu J; Yi B; Mao J; Huang J; Yang S; Zhang H
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 May; 41(5):445-54. PubMed ID: 27269917
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential Prognostic Utility of Adiposity Measures in Chronic Kidney Disease.
    Cejka V; Störk S; Nadal J; Schmid M; Sommerer C; Sitter T; Meiselbach H; Busch M; Schneider MP; Saritas T; Schultheiss UT; Kotsis F; Wanner C; Eckardt KU; Krane V;
    J Ren Nutr; 2023 Jul; 33(4):546-554. PubMed ID: 37116626
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Obesity measures at baseline, their trajectories over time, and the incidence of chronic kidney disease: A 14 year cohort study among Korean adults.
    Zhang HS; An S; Ahn C; Park SK; Park B
    Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):782-792. PubMed ID: 33546946
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association Between Obesity and Chronic Kidney Disease, Defined by Both Glomerular Filtration Rate and Albuminuria, in Korean Adults.
    Kim YJ; Hwang SD; Oh TJ; Kim KM; Jang HC; Kimm H; Kim HC; Jee SH; Lim S
    Metab Syndr Relat Disord; 2017 Oct; 15(8):416-422. PubMed ID: 28832275
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association Between Obesity and Microvascular Diseases in Patients With Type 2 Diabetes Mellitus.
    Gao S; Zhang H; Long C; Xing Z
    Front Endocrinol (Lausanne); 2021; 12():719515. PubMed ID: 34764938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study.
    ; Langenberg C; Sharp SJ; Schulze MB; Rolandsson O; Overvad K; Forouhi NG; Spranger J; Drogan D; Huerta JM; Arriola L; de Lauzon-Guillan B; Tormo MJ; Ardanaz E; Balkau B; Beulens JW; Boeing H; Bueno-de-Mesquita HB; Clavel-Chapelon F; Crowe FL; Franks PW; Gonzalez CA; Grioni S; Halkjaer J; Hallmans G; Kaaks R; Kerrison ND; Key TJ; Khaw KT; Mattiello A; Nilsson P; Norat T; Palla L; Palli D; Panico S; Quirós JR; Romaguera D; Romieu I; Sacerdote C; Sánchez MJ; Slimani N; Sluijs I; Spijkerman AM; Teucher B; Tjonneland A; Tumino R; van der A DL; van der Schouw YT; Feskens EJ; Riboli E; Wareham NJ
    PLoS Med; 2012; 9(6):e1001230. PubMed ID: 22679397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Annual variation in body fat is associated with systemic inflammation in chronic kidney disease patients Stages 3 and 4: a longitudinal study.
    Carvalho LK; Barreto Silva MI; da Silva Vale B; Bregman R; Martucci RB; Carrero JJ; Avesani CM
    Nephrol Dial Transplant; 2012 Apr; 27(4):1423-8. PubMed ID: 21825305
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Use of Anthropometric Measurements of Obesity in Prediction of Microvascular Complications in Obese Type 2 Diabetic Patients.
    Bulum T; Blaslov K; Duvnjak L
    Acta Clin Croat; 2016 Jun; 55(2):217-23. PubMed ID: 28394108
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than fatty liver or nonalcoholic fatty liver disease.
    Tanaka M; Mori K; Takahashi S; Higashiura Y; Ohnishi H; Hanawa N; Furuhashi M
    Nephrol Dial Transplant; 2023 Feb; 38(3):700-711. PubMed ID: 35612975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Association of elevated blood serum high-sensitivity C-reactive protein levels and body composition with chronic kidney disease: A population-based study in Taiwan.
    Tsai YW; Chan YL; Chen YC; Cheng YH; Chang SS
    Medicine (Baltimore); 2018 Sep; 97(36):e11896. PubMed ID: 30200074
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Obesity indices and adipokines in non-diabetic obese patients with early stages of chronic kidney disease.
    Stępień M; Stępień A; Wlazeł RN; Paradowski M; Banach M; Rysz M; Rysz J
    Med Sci Monit; 2013 Nov; 19():1063-72. PubMed ID: 24280776
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of weight loss on the estimated glomerular filtration rates of obese patients at risk of chronic kidney disease: the RIGOR-TMU study.
    Lin YC; Lai YJ; Lin YC; Peng CC; Chen KC; Chuang MT; Wu MS; Chang TH
    J Cachexia Sarcopenia Muscle; 2019 Aug; 10(4):756-766. PubMed ID: 30938491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Obesity index and the risk of diabetes among Chinese women with prior gestational diabetes.
    Wang L; Liu H; Zhang S; Leng J; Liu G; Zhang C; Li WQ; Li N; Li W; Li Y; Sun S; Yu Z; Yang X; Hu G
    Diabet Med; 2014 Nov; 31(11):1368-77. PubMed ID: 24961948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.